Thermo Fisher Scientific Inc (TMO)

TMO (NYSE:Health Services) EQUITY
$173.42
pos +0.00
+0.00%
Today's Range: 172.88 - 173.56 | TMO Avg Daily Volume: 1,580,300
Last Update: 05/26/17 - 4:00 PM EDT
Volume: 0
YTD Performance: 22.54%
Open: $0.00
Previous Close: $172.90
52 Week Range: $139.07 - $173.64
Oustanding Shares: 391,219,918
Market Cap: 67,641,923,822
6-Month Chart
TheStreet Ratings Grade for TMO
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 12 12 12 12
Moderate Buy 0 1 1 1
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 1 1
Mean Rec. 1.15 1.18 1.43 1.43
Latest Dividend: 0.15
Latest Dividend Yield: 0.35%
Dividend Ex-Date: 06/13/17
Price Earnings Ratio: 31.49
Price Earnings Comparisons:
TMO Sector Avg. S&P 500
31.49 31.60 29.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
8.76% 14.70% 49.39%
GROWTH 12 Mo 3 Yr CAGR
Revenue 7.70 0.40 0.12
Net Income 2.30 0.60 0.16
EPS 3.50 0.50 0.13
Earnings for TMO:
EBITDA 4.40B
Revenue 18.27B
Average Earnings Estimates
Qtr (06/17) Qtr (09/17) FY (12/17) FY (12/18)
Average Estimate $2.26 $2.24 $9.22 $10.22
Number of Analysts 11 9 13 11
High Estimate $2.28 $2.28 $9.25 $10.81
Low Estimate $2.22 $2.21 $9.20 $10.03
Prior Year $2.03 $2.03 $8.27 $9.22
Growth Rate (Year over Year) 11.33% 10.56% 11.46% 10.89%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
RMPIA
By

The Deal

 | Mar 27, 2016 | 2:00 PM EDT

As Valeant launches allegations of improper financial reporting at its former CFO, experts say it ought to take a close look at the...

RMPIA
By

Bruce Kamich

 | Mar 21, 2016 | 10:08 AM EDT

We would anticipate a breakout to upside; a decline below $130 would turn us neutral on TMO. 

RMPIA
By

Jim Cramer and the AAP Team

 | Feb 1, 2016 | 10:00 AM EST

Stanley Black & Decker and Thermo Fisher provide an unfortunate lesson.

RMPIA
By

Jim Cramer and the AAP Team

 | Dec 13, 2015 | 5:00 PM EST

While we don't want to alarm readers, we are increasingly concerned around the market's movement heading into year-end.

RMPIA
By

Jim Cramer and the AAP Team

 | Dec 4, 2015 | 8:00 AM EST

Let's break it down into several components.

RMPIA
By

Bruce Kamich

 | Oct 9, 2015 | 11:59 AM EDT

Momentum readings are improving.

RMPIA
By

David Katz

 | Sep 23, 2015 | 7:00 AM EDT

The management recently gave a very upbeat presentation.

RMPIA
By

Robert Moreno

 | Jun 23, 2015 | 11:30 AM EDT

TMO is a buy after a strong close above the wedge downtrend line.

RMPIA
By

Jack Mohr

 | May 13, 2015 | 3:52 PM EDT

There's no reason for Thermo to start a bidding war.

RMPIA
By

Jim Cramer

 | May 13, 2015 | 3:10 PM EDT

Companies get proactive to boost their stocks.

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.